BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17890090)

  • 1. Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study.
    Bristow AR; Agrawal A; Evans AJ; Burrell HC; Cornford EJ; James JJ; Hamilton L; Robertson JF; Chan SY; Lawton PA; Cheung KL
    Breast; 2008 Feb; 17(1):98-103. PubMed ID: 17890090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of (18)F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis.
    Niikura N; Hashimoto J; Kazama T; Koizumi J; Ogiya R; Terao M; Oshitanai R; Morioka T; Tsuda B; Okamura T; Saito Y; Iwaisako K; Iwamoto T; Hayashi N; Imai Y; Tokuda Y
    Breast Cancer; 2016 Jul; 23(4):662-7. PubMed ID: 26037335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.
    Schirrmeister H; Buck A; Guhlmann A; Reske SN
    Thyroid; 2001 Jul; 11(7):677-83. PubMed ID: 11484897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
    McCartan DP; Prichard RS; MacDermott RJ; Rothwell J; Geraghty J; Evoy D; Quinn CM; Skehan SJ; O'Doherty A; McDermott EW
    Br J Surg; 2016 Jun; 103(7):839-44. PubMed ID: 27004443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone scan and liver ultrasound scan in the preoperative staging for primary breast cancer.
    Kasem AR; Desai A; Daniell S; Sinha P
    Breast J; 2006; 12(6):544-8. PubMed ID: 17238984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
    Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
    Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline staging tests in primary breast cancer: a practice guideline.
    Myers RE; Johnston M; Pritchard K; Levine M; Oliver T;
    CMAJ; 2001 May; 164(10):1439-44. PubMed ID: 11387916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer].
    Tamada T; Nagai K; Iizuka M; Imai S; Kajihara Y; Yamamoto S; Kurebayashi J; Shimozuma K; Sonoo H; Fukunaga M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Apr; 60(5):249-54. PubMed ID: 10824532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Bone Reading CT software on radiologist performance in detecting bone metastases from breast cancer.
    Ha JY; Jeon KN; Bae K; Choi BH
    Br J Radiol; 2017 Apr; 90(1072):20160809. PubMed ID: 28256905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planar Bone Scan Versus Computerized Tomography in Staging Locally Advanced Breast Cancer in Asymptomatic Patients: Does Bone Scan Change Patient Management Over Computerized Tomography?
    Bansal GJ; Vinayan Changaradil D
    J Comput Assist Tomogr; 2018; 42(1):19-24. PubMed ID: 28786907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer.
    Prior JO; Barghouth G; Delaloye JF; Leyvraz S; Bischof Delaloye A
    Nucl Med Commun; 2003 Jan; 24(1):29-36. PubMed ID: 12501017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma.
    Jin YJ; Lee HC; Lee D; Shim JH; Kim KM; Lim YS; Do KH; Ryu JS
    J Hepatol; 2012 Jun; 56(6):1324-9. PubMed ID: 22322236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen].
    Dose-Schwarz J; Mahner S; Schirrmacher S; Jenicke L; Müller V; Habermann CR; Brenner W
    Nuklearmedizin; 2008; 47(3):97-103. PubMed ID: 18493688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metastatic bone disease. Strategies for imaging].
    Scutellari PN; Antinolfi G; Galeotti R; Giganti M
    Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic imaging of bone metastases].
    Scutellari PN; Addonisio G; Righi R; Giganti M
    Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.